Internal Medicine, Medical Oncology · Zion, IL
NPI
1073786745
Since 2008
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
Cancer Treatment Centers of America, 2520 Elisha Avenue
Zion, IL, 60099
Phone (800) 322-9183
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
985 services
Medicare patients, 2024
306
Average age 70
Drug cost, 2024
$1.7M
745 prescriptions
Company payments, 2025
$454
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laura C Farrington was code 99214 (office e&m - established), 301 times for 181 patients. In total Laura C Farrington billed 985 services in 12 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 301 | 181 | $73.59 | $22K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 280 | 197 | $12.92 | $3,618 |
| 99215 Office E&M - Established | Facility | 217 | 147 | $110.00 | $24K |
| 99213 Office E&M - Established | Facility | 75 | 59 | $45.45 | $3,409 |
| 99205 Office E&M - New | Facility | 43 | 43 | $139.78 | $6,011 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 16 | 14 | $24.89 | $398 |
By year: 2022 $45K for 519 services; 2023 $53K for 656 services; 2024 $63K for 985 services.
Medicare prescription drug claims, 2024
In 2024, the drug Laura C Farrington prescribed most often to Medicare patients was Anastrozole, with 79 prescriptions and refills. In total Laura C Farrington wrote 745 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 79 | 210 | 33 | $2,025 |
| Levothyroxine Sodium Generic | 47 | 111 | 16 | $311 |
| Gabapentin Generic | 42 | 64 | 12 | $349 |
| Ondansetron Odt Ondansetron | 40 | 42 | 30 | $407 |
| Letrozole Generic | 39 | 94 | 13 | $660 |
| Dexamethasone Generic | 27 | 29 | 11 | $295 |
| Prochlorperazine Maleate Generic | 27 | 27 | 23 | $516 |
| Loperamide Loperamide Hcl | 21 | 21 | 21 | $240 |
| Exemestane Generic | 20 | 57 | Under 11 | $1,982 |
| Tramadol Hcl Generic | 19 | 19 | Under 11 | $82.41 |
| Prednisone Generic | 15 | 16 | Under 11 | $79.09 |
| Omeprazole Generic | 15 | 20 | Under 11 | $92.29 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 14 | 14 | Under 11 | $79.03 |
| Arimidex Anastrozole | 12 | 12 | Under 11 | $23K |
| Lynparza Olaparib | 12 | 12 | Under 11 | $137K |
Brand drugs: 144 claims; generic drugs: 601 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laura C Farrington $454 ($454 in general payments such as food, travel and fees) from 10 companies. The largest payer was Gilead Sciences, Inc. with $190.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 4 | $190 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $50.34 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $43.47 |
| Merck Sharp & Dohme LLC MRK | 1 | $35.27 |
| Eisai Inc. 4523.T | 1 | $34.25 |
| Pfizer Inc. PFE | 1 | $27.74 |
| SpringWorks Therapeutics, Inc. | 1 | $27.38 |
| Daiichi Sankyo Inc. 4568.T | 1 | $27.17 |
| GlaxoSmithKline, LLC. GSK | 1 | $18.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.